University of Minnesota, School of Nursing, 308 Southeast Harvard Street, Minneapolis, MN 55455, USA.
Heart Lung. 2020 Sep-Oct;49(5):463-474. doi: 10.1016/j.hrtlng.2020.02.045. Epub 2020 Apr 2.
Left ventricular assist device-destination therapy (LVAD-DT) represents a powerful technology capable of prolonging and significantly altering recipients' lives. The objective of this systematic review is to analyze the experiences of LVAD-DT recipients and recommend directions of further study. This is a qualitative research project; a systematic review, using thematic meta-synthesis. Six studies were reviewed. Three over-arching themes supported by seven conceptual categories were recognized across the six studies. The three overarching themes are that LVAD-DT recipients continue to struggle with complex support needs post implantation; the motivations for accepting LVAD-DT is death avoidance, and symptom relief; and, that recipients often believe the device will reverse or fix their heart failure. Although elemental, these themes suggest LVAD-DT recipients' interests may not be well served by the informed consent process. The number of LVAD-DT recipients continues to grow and age, presenting significant implications for healthcare providers as a result of this finding.
左心室辅助装置-终末期心衰治疗（LVAD-DT）是一种强大的技术，能够延长和显著改变患者的生命。本系统综述的目的是分析 LVAD-DT 受者的经验，并为进一步研究推荐方向。这是一个定性研究项目；系统综述，使用主题元综合法。共审查了六项研究。在这六项研究中，确定了三个由七个概念类别支撑的总体主题。这三个总体主题是，LVAD-DT 受者在植入后继续面临复杂的支持需求；接受 LVAD-DT 的动机是避免死亡和缓解症状；以及受者通常认为该设备将逆转或修复他们的心力衰竭。尽管这些主题很基本，但它们表明 LVAD-DT 受者的利益可能没有得到知情同意过程的很好服务。随着 LVAD-DT 受者数量的不断增加和年龄的增长，这一发现给医疗保健提供者带来了重大影响。
